Anti-CD3 nanobody CD3/Nb29 and preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- GUANGXI MEDICAL UNIVERSITY
- Publication Date
- 2019-09-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to anti-CD3 nanobody CD3 / Nb29 in the field of biomedicine and its preparation method and application. Background technique
[0002] CD3 molecule is an important differentiation antigen on the T cell membrane and a characteristic mark of mature T cells. It forms a complex with the T cell surface receptor TCR and plays an important role in intracellular signal transduction. CD3 antibody can specifically recognize CD3 molecules on the surface of T cells, causing cross-linking of T cell TCR-CD3 complexes, directly generating activation signals, leading to activation and proliferation of T cells. Current research shows that CD3 antibody plays an important role in tumor treatment.
[0003] However, there are many problems in the application of antibody drugs, such as long research and development cycle, high production cost, difficulty in large-scale production, poor stability and easy degradation, high storage cost, easy contaminatio...